ScreenerHero

RAY-B RaySearch Laboratories AB (publ)

STO · SE · Healthcare · Health Information Services · raysearchlabs.com
185.50SEK+0.98%Mkt Cap: 523.69M $P/E: 29.53

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology infor…

Industry Peers

Health Information Services
Screen all
VEEV
Veeva Systems Inc.
$45.89BUSDP/E 46.5
TEM
Tempus AI, Inc.
$15.08BUSD
BTSG
BrightSpring Health Services, Inc.
$12.27BUSDP/E 54.9
HNGE
Hinge Health, Inc.
$7.94BUSDP/E 32.5
HQY
HealthEquity, Inc.
$7.57BUSDP/E 33.1
DOCS
Doximity, Inc.
$5.09BUSDP/E 33.6
WAY
Waystar Holding Corp.
$5.08BUSDP/E 37.8
HTFL
Heartflow, Inc.
$4.54BUSD
PRVA
Privia Health Group, Inc.
$2.61BUSDP/E 97.4
SDGR
Schrödinger, Inc.
$2.44BUSD
OMCL
Omnicell, Inc.
$1.58BUSDP/E 41.2
CERT
Certara, Inc.
$1.54BUSD
OMDA
Omada Health, Inc.
$1.28BUSDP/E 87.3
GDRX
GoodRx Holdings, Inc.
$1.15BUSDP/E 67.2
TDOC
Teladoc Health, Inc.
$1.05BUSD
HSTM
HealthStream, Inc.
$964.99MUSDP/E 43.8
SOPH
SOPHiA GENETICS SA
$698.05MUSD
PHR
Phreesia, Inc.
$643.68MUSDP/E 61.0
WEAV
Weave Communications, Inc.
$592.12MUSD
MDRX
Veradigm Inc.
$516.62MUSD

Key Statistics

Company
Market Cap523.69M USD
Enterprise Value596.00M USD
Revenue (TTM)121.47M USD
Gross Profit118.84M USD
Net Income (TTM)21.79M USD
Revenue/Share37.14 SEK
Last Price185.50 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees464
CountrySE
SectorHealthcare
IndustryHealth Information Services
ISINSE0000135485
Valuation
P/E (Trailing)29.53
P/E (Forward)26.97
PEG25.65
EV/EBITDA18.10
EV/Revenue4.91
P/S4.25
P/B5.95
EPS (TTM)6.22
EPS (Forward)6.71
52W Range
153.1029% of range264.50
52W High264.50 SEK
52W Low153.10 SEK
Profitability
Gross Margin92.42%
Oper. Margin10.32%
EBITDA Margin27.11%
Profit Margin16.95%
ROE23.12%
ROA11.44%
Growth
Revenue Growth-10.70%
Earnings Growth-36.60%
Cash Flow & Leverage
Operating CF37.02M USD
CapEx (TTM)21.82M USD
FCF Margin10.31%
FCF Yield2.39%
Net Debt13.97M USD
Net Debt/EBITDA0.42
Balance Sheet
Debt/Equity0.40
Current Ratio1.29
Quick Ratio1.23
Book Value/Sh30.41 SEK
Cash/Share6.34 SEK
Dividends
Fwd Div Rate4.00 SEK
Trail. Div Rate4.00 SEK
Div. Yield2.21%
5Y Avg Yield—
Payout Ratio64.21%
Ex-Div DateMay 8, 2026
Pay Date—
Splits
Last Split3:1
Split DateJun 25, 2008
Analyst Consensus
Rating—
Target (Mean)297.50 SEK
Upside (mean)+60.4%
Target Range250.00 SEK – 345.00 SEK
250.00+60.4% to mean345.00
# Analysts2
Ownership
Shares Out.29.80M
Float27.41M
Insiders10.85%
Institutions56.73%
Technical
SMA 50179.44 (+3.4%)
SMA 200196.50 (-5.6%)
Beta0.92
S&P 52W Chg14.58%
Avg Vol (30d)147.29K
Avg Vol (10d)176.35K
Technical Indicators
RSI (14)55.0
MACD0.6772
MACD Signal-0.9792
MACD Hist.+1.6564
BB Upper187.10 SEK
BB Middle176.41 SEK
BB Lower165.72 SEK
BB Width12.12%
ATR (14)6.333 SEK
Vol Ratio (20d)0.40x